Melina Masihi, MD, PhD, is a physician-scientist and healthcare leader with more than 15 years of experience in clinical practice, research, and program leadership. As former Director of Clinical Programs at Northwestern Hospital, she led initiatives to improve clinical pathways, accelerate diagnosis, expand access to care, and strengthen the patient experience across gastroenterology, oncology, and hematology.

Dr. Masihi has contributed to more than 70 clinical trials and collaborated with leading pharmaceutical and medical technology organizations, including AstraZeneca, Merck, Medtronic, and Boehringer Ingelheim. She also serves with the Stanford High Impact Technology Fund, evaluating early-stage healthcare innovations that address unmet patient needs.

Her work is centered on advancing compassionate, accessible, and patient-focused care while improving outcomes for both healthcare teams and the communities they serve.